Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-Chamber Parenteral Nutrition Formulation (Oliclinomel N4)

NCT01579097 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.

NCT NCT01579097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01579097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-Chamber Parenteral Nutrition Formulation (Oliclinomel N4)
Lead sponsor
Baxter Healthcare Corporation
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2011
Completion date
January 31, 2013
Enrollment
458 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nutrition support